By: Marae Mars
ISCHEMIC STROKE AND EPILEPSY
I. Introduction
Ischemic stroke is one of the leading causes of acquired neurological disability, responsible for roughly 87 percent of all stroke cases worldwide. It occurs when an obstruction in a cerebral artery deprives brain tissue of oxygen and glucose, initiating a biochemical cascade that ultimately leads to cellular death. While rapid intervention can save lives, the long-term neurological effects of an ischemic episode often unfold long after the initial event. Among the most consequential of these is post-stroke epilepsy (PSE), the emergence of recurrent, unprovoked seizures following a cerebrovascular accident. The link between ischemic stroke and epilepsy reflects a complex interplay of vascular injury, neuroinflammation, and maladaptive neuroplasticity. During ischemia, energy failure and excitotoxic neurotransmitter release disrupt the brain’s delicate balance between excitation and inhibition. As the tissue attempts to recover, rewiring and glial scarring can form hyper-excitable networks that generate epileptic activity. Thus, the same mechanisms that promote healing may paradoxically foster seizure susceptibility. Recognizing how ischemic injury evolves into epileptogenesis is essential for improving both acute management and long-term rehabilitation.
II. Overview of Ischemic Stroke
An ischemic stroke occurs when cerebral blood flow is obstructed, preventing oxygen and glucose from reaching neural tissue. This blockage is typically caused by either thrombosis, a blood clot forming within a cerebral artery, or embolism, a clot or fragment of debris that travels from another part of the body and lodges in a smaller vessel within the brain. Regardless of the mechanism, the outcome is the same: the affected region experiences a rapid decline in energy availability, leading to cellular stress, ion imbalance, and ultimately, neuronal death.
The severity and reversibility of ischemic injury depend largely on the area deprived of blood flow. The ischemic core represents the central zone of the infarct where blood flow ceases almost entirely. In this region, neurons undergo irreversible damage within minutes due to catastrophic energy failure and loss of membrane potential. Surrounding this core is the ischemic penumbra, a functionally impaired yet metabolically active zone that remains partially perfused through collateral circulation. This tissue is potentially salvageable if reperfusion is achieved promptly, making it the primary target of acute stroke therapies such as thrombolytics and endovascular intervention.
Certain vascular territories are more commonly affected by ischemic events, particularly the middle cerebral artery (MCA), which supplies extensive portions of the frontal, parietal, and temporal lobes. Occlusion of the MCA often results in hemiplegia, facial droop, or aphasia, depending on the hemisphere involved. Damage to cortical regions is especially significant in the context of epilepsy, as cortical neurons are highly excitable and prone to forming aberrant electrical networks after injury. Conversely, subcortical strokes, which affect deeper brain structures such as the basal ganglia or internal capsule, may present with different motor and sensory deficits but carry a relatively lower risk of epileptogenesis.
Ultimately, the cellular and regional consequences of ischemic stroke lay the groundwork for long-term neurological complications. Understanding how these acute mechanisms evolve into chronic network dysfunction provides critical insight into why some patients develop post-stroke epilepsy while others recover without recurrent seizures.
III. Pathophysiology Linking Stroke to Epilepsy
After an ischemic stroke, a series of biochemical and structural changes can transform normal brain tissue into an epileptogenic network. The major contributors to this process include excitotoxicity, ion imbalance, inflammation and gliosis, and synaptic reorganization. During ischemia, oxygen and glucose deprivation cause neurons to release excessive amounts of glutamate, overstimulating NMDA and AMPA receptors. This excitotoxicity leads to uncontrolled influxes of calcium and sodium ions, which damage cell membranes, impair mitochondria, and make surviving neurons hyperexcitable. The resulting disruption of ion homeostasis further lowers the threshold for neuronal firing, amplifying excitatory activity across nearby circuits. As the brain attempts to heal, inflammation and gliosis develop. Activated microglia and astrocytes release inflammatory molecules meant to repair tissue but often end up promoting long-term instability. Scarring from gliosis alters neurotransmitter uptake and weakens inhibitory control, sustaining the hyperexcitable environment.
Over time, the injured brain undergoes synaptic reorganization, sprouting new and sometimes abnormal connections. These maladaptive circuits can synchronize firing patterns abnormally, creating self-sustaining regions of seizure activity. Clinically, post-stroke seizures are categorized as acute symptomatic, occurring within the first week of the stroke, or late-onset, appearing weeks to months later as part of post-stroke epilepsy (PSE). Early seizures often signal a higher risk for developing chronic epilepsy, underscoring the importance of ongoing monitoring and intervention.
IV. Epidemiology and Risk Factors
Post-stroke epilepsy (PSE) is one of the most common long-term complications of stroke, occurring in approximately 5–15% of survivors. The likelihood of developing seizures depends on several clinical and anatomical factors related to the nature of the stroke and the patient’s individual characteristics.
The risk of epilepsy is highest in patients with cortical strokes, where neuronal networks responsible for electrical signaling are directly affected. Large infarcts and cases involving hemorrhagic transformation further increase susceptibility due to greater tissue destruction and irritation of surrounding brain regions. Younger patients also face a higher risk, likely because their brains exhibit greater neuroplasticity, which can facilitate both recovery and maladaptive network rewiring that leads to seizure activity. Clinically, post-stroke seizures are divided by timing. Early seizures, occurring within seven days of the initial event, are often provoked by acute metabolic disturbances and tissue injury. Late seizures, appearing after seven days, are typically unprovoked and reflect lasting structural and functional changes, the hallmark of post-stroke epilepsy.
V. Diagnosis
Post-stroke seizures typically present as focal onset seizures, which may be focal aware (without loss of consciousness), focal impaired awareness, or evolve into secondary generalized seizures. These often arise from cortical regions adjacent to the infarcted area, where neuronal hyperexcitability develops due to ischemic injury and reorganization. Electroencephalography (EEG) is a key diagnostic tool, frequently showing epileptiform discharges localized near the stroke site. Such findings confirm abnormal cortical activity and help distinguish epileptic events from other neurological complications. Magnetic resonance imaging (MRI) may reveal gliotic scarring, cortical laminar necrosis, or other structural changes consistent with chronic tissue damage that predisposes to seizures.
Accurate diagnosis also requires differentiation from transient ischemic attacks (TIAs), which can mimic seizure-like symptoms such as weakness, confusion, or speech difficulty. Unlike TIAs, post-stroke seizures are characterized by abnormal electrical discharges on EEG and are not associated with new ischemic events. Recognizing these distinctions is essential for initiating appropriate treatment and long-term management.
VI. Treatment and Management
Management of post-stroke seizures focuses on both acute seizure control and long-term prevention of recurrent episodes. In the acute phase, benzodiazepines such as lorazepam or diazepam are the first-line agents for rapid seizure termination. For ongoing therapy, antiseizure medications (ASMs) are prescribed based on efficacy, side effect profile, and patient comorbidities. Levetiracetam, lamotrigine, and lacosamide are commonly preferred due to their minimal drug interactions and good tolerability in elderly patients. Enzyme-inducing ASMs, including phenytoin and carbamazepine, are generally avoided in post-stroke populations because they can interfere with other medications used for vascular management and exacerbate cognitive side effects.
Secondary stroke prevention remains a key aspect of overall care, involving the use of antiplatelet or anticoagulant therapy, strict control of blood pressure, glucose, and cholesterol, and lifestyle modifications to reduce vascular risk factors. Continuous EEG monitoring is often recommended to detect subclinical seizure activity, especially in patients with altered mental status or unexplained neurological changes. Effective recovery also relies on multidisciplinary coordination between neurologists, epileptologists, and rehabilitation specialists to optimize both seizure management and functional outcomes.
VII. Prognosis
Following an ischemic stroke, the brain undergoes extensive neuroplastic reorganization as surviving neurons form new connections to compensate for damaged pathways. This adaptive process supports functional recovery in motor control, speech, and cognition. However, the same plasticity that enables healing can also promote epileptogenic network formation, as excessive or misdirected synaptic growth increases the likelihood of abnormal synchronous firing and seizure activity. Neurorehabilitation plays a critical role in guiding this reorganization toward positive outcomes. Targeted therapies, including physical, occupational, and cognitive rehabilitation, help strengthen beneficial neural pathways while minimizing maladaptive patterns. Advances in non-invasive brain stimulation, such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), have shown promise in enhancing recovery and modulating cortical excitability to reduce post-stroke seizure risk.
Patients facing both stroke and epilepsy often experience compounded cognitive and emotional challenges, including memory deficits, depression, and anxiety. These factors significantly affect the quality of life and long-term independence. Consequently, effective management requires a multidisciplinary approach, integrating neurologists, epileptologists, rehabilitation specialists, and mental health professionals to address both neurological recovery and psychosocial well-being.
VIII. Conclusion
Ischemic stroke can set in motion a series of neurological and cellular events that reshape the brain long after the initial injury. Through excitotoxicity, disrupted ion balance, inflammation, and maladaptive neuroplasticity, damaged neural networks may reorganize in hyperexcitable circuits capable of generating spontaneous seizures. This transformation from vascular injury to epileptogenesis underscores the brain’s vulnerability, but also its complexity, in attempting to recover from ischemic trauma. Preventing and managing post-stroke epilepsy requires early detection, consistent monitoring, and strong patient education to reduce long-term complications. By promoting awareness of the link between stroke and epilepsy, healthcare professionals can better guide survivors through both recovery and prevention.
Resources:
Altman, K., Shavit-Stein, E., & Maggio, N. (2019). Post stroke seizures and epilepsy: From proteases to maladaptive plasticity. Frontiers in Cellular Neuroscience. Retrieved from https://www.frontiersin.org/articles/10.3389/fncel.2019.00397/full
Chen, J., et al. (2022). Pathogenesis of seizures and epilepsy after stroke. AEPI: Advances in Experimental Medicine and Biology / BMC Neurology Journal. Retrieved from https://aepi.biomedcentral.com/articles/10.1186/s42494-021-00068-8
Ferro, J. M. (2004). Poststroke epilepsy: Epidemiology, pathophysiology and therapeutic approaches. Journal Name / relevant neurology review. Retrieved from PubMed summary page https://pubmed.ncbi.nlm.nih.gov/15287823/
Freiman, S., et al. (2023). Post-stroke seizures, epilepsy, and mortality in a prospective hospital cohort. Frontiers in Neurology. Retrieved from https://www.frontiersin.org/articles/10.3389/fneur.2023.1273270/full
Ryu, H. U., et al. (2024). Clinical approaches for poststroke seizure: A review. Frontiers in Neurology. Retrieved from https://www.frontiersin.org/articles/10.3389/fneur.2024.1337960/full
Zöllner, J. P., et al. (2021). Seizures and epilepsy in patients with ischemic stroke: A narrative review. Neurology – Research & Practice. Retrieved from https://neurolrespract.biomedcentral.com/articles/10.1186/s42466-021-00161-w BioMed Central
